Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
SRTS on Nasdaq
Shares outstanding
16,385,263
Price per share
$3.98
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,295,224
Total reported value
$13,118,970
% of total 13F portfolios
0%
Share change
-113,288
Value change
-$424,869
Number of holders
31
Price from insider filings
$3.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Solot Edwin Lee 7.6% $5,827,910 1,245,280 Edwin L. Solot, Jr. 31 Dec 2024

As of 31 Dec 2025, 31 institutional investors reported holding 3,295,224 shares of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS). This represents 20% of the company’s total 16,385,263 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.4% 728,916 0% 0% $2,901,086
Pacific Ridge Capital Partners, LLC 4.3% 698,634 +22% 0.61% $2,780,563
DIMENSIONAL FUND ADVISORS LP 2.7% 443,638 -22% 0% $1,765,166
RENAISSANCE TECHNOLOGIES LLC 1.6% 257,034 -1.6% 0% $1,022,995
GEODE CAPITAL MANAGEMENT, LLC 0.97% 158,240 +3.5% 0% $629,932
Sachetta, LLC 0.91% 148,508 +6.8% 0.32% $591,064
UBS Group AG 0.83% 135,843 +8.8% 0% $540,655
Greenline Wealth Management LLC 0.79% 128,774 0% 0.53% $512,521
Bank of New York Mellon Corp 0.76% 124,546 0% 0% $495,694
BlackRock, Inc. 0.43% 70,755 -3.4% 0% $281,605
STATE STREET CORP 0.42% 69,252 +5.2% 0% $275,623
ACADIAN ASSET MANAGEMENT LLC 0.35% 57,300 -75% 0% $227,000
INGALLS & SNYDER LLC 0.34% 55,000 0.01% $219,000
MINDSET WEALTH MANAGEMENT, LLC 0.32% 52,100 +4% 0.05% $207,358
Janney Montgomery Scott LLC 0.25% 40,576 0% 0% $161,000
AMERICAN CENTURY COMPANIES INC 0.13% 21,272 0% 0% $84,663
JANE STREET GROUP, LLC 0.12% 19,880 0% $79,122
Opes Wealth Management LLC 0.1% 16,065 0% 0.01% $63,939
GARRISON BRADFORD & ASSOCIATES INC 0.08% 12,500 0% 0.05% $49,750
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.07% 12,078 0% 0% $53,868
Vise Technologies, Inc. 0.07% 11,000 0% 0% $43,780
CHAPIN DAVIS, INC. 0.06% 10,000 -60% 0.01% $39,800
MORGAN STANLEY 0.04% 6,267 -20% 0% $24,943
SIMPLEX TRADING, LLC 0.04% 5,938 +84% 0% $23,633
Larson Financial Group LLC 0.03% 5,441 0% 0% $21,655

Institutional Holders of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,295,224 $13,118,970 -$424,869 $3.98 31
2025 Q3 4,213,544 $13,235,817 -$716,846 $3.14 42
2025 Q2 4,345,464 $20,596,029 +$1,512,062 $4.74 46
2025 Q1 4,026,834 $19,046,437 -$6,276,532 $4.73 53
2024 Q4 4,903,533 $33,920,348 +$6,954,088 $6.92 65
2024 Q3 3,885,568 $22,593,506 +$3,373,159 $5.80 50
2024 Q2 3,273,489 $17,552,838 +$4,434,599 $5.33 47
2024 Q1 2,481,212 $9,277,180 -$140,014 $3.80 45
2023 Q4 2,617,403 $6,188,682 -$467,743 $2.36 40
2023 Q3 2,661,310 $7,368,535 -$2,226,146 $2.77 40
2023 Q2 3,414,591 $10,755,535 -$7,918,322 $3.15 49
2023 Q1 4,900,010 $25,524,883 -$1,697,795 $5.21 66
2022 Q4 5,076,199 $37,640,159 -$13,766,550 $7.42 66
2022 Q3 6,115,199 $76,605,789 +$14,256,431 $12.53 77
2022 Q2 5,091,341 $39,116,200 +$6,033,503 $7.68 56
2022 Q1 4,419,085 $44,720,750 +$21,822,621 $10.12 53
2021 Q4 2,277,916 $16,438,000 +$8,095,278 $7.22 37
2021 Q3 1,309,389 $4,714,000 +$14,842 $3.60 18
2021 Q2 1,302,714 $5,014,000 -$279,059 $3.85 18
2021 Q1 1,376,215 $5,267,000 +$241,320 $3.82 20
2020 Q4 1,312,808 $5,067,000 +$189,276 $3.86 17
2020 Q3 1,267,945 $3,195,000 -$285,048 $2.52 20
2020 Q2 1,140,216 $3,499,000 -$583,507 $3.06 17
2020 Q1 1,604,962 $4,013,000 -$402,172 $2.50 19
2019 Q4 1,749,713 $6,193,000 -$362,070 $3.54 20
2019 Q3 1,700,318 $10,203,000 -$503,691 $6.00 16
2019 Q2 1,785,935 $9,893,000 -$395,687 $5.54 15
2019 Q1 1,791,299 $12,574,000 +$3,269,059 $7.02 22
2018 Q4 1,324,776 $9,814,000 -$8,568,638 $7.40 13
2018 Q3 2,324,079 $19,475,000 +$7,626,156 $8.38 22
2018 Q2 1,414,057 $10,267,000 +$2,375,622 $7.26 13
2018 Q1 1,113,727 $6,731,000 +$154,381 $5.84 12
2017 Q4 1,087,249 $5,641,000 -$228,141 $5.17 11
2017 Q3 1,134,209 $5,647,000 +$274,216 $4.98 13
2017 Q2 1,089,976 $4,382,000 +$405,660 $4.02 10
2017 Q1 1,195,758 $5,249,000 +$397,231 $4.39 12
2016 Q4 1,105,095 $5,792,000 +$347,849 $5.25 10
2016 Q3 1,038,642 $6,387,000 +$6,387,000 $6.15 9